{"id":"NCT00528112","sponsor":"Bayer","briefTitle":"Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study","officialTitle":"Multi-Center, Open-Label, Randomized Study to Assess the Safety and Contraceptive Efficacy of Two Doses ( in vitro12 µg/24h and 16 µg/24h) of the Ultra Low Dose Levonorgestrel Contraceptive Intrauterine Systems (LCS) for a Maximum of 3 Years in Women 18 to 35 Years of Age and an Extension Phase of the 16µg/24h Dose Group (LCS16 Arm) up to 5 Years","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-08","primaryCompletion":"2011-07","completion":"2013-06","firstPosted":"2007-09-12","resultsPosted":"2012-09-24","lastUpdate":"2017-01-25"},"enrollment":2885,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Contraception"],"interventions":[{"type":"DRUG","name":"LCS12","otherNames":[]},{"type":"DRUG","name":"LCS16","otherNames":[]}],"arms":[{"label":"LCS12","type":"EXPERIMENTAL"},{"label":"LCS16","type":"EXPERIMENTAL"}],"summary":"This is a study on a new low dose levonorgestrel contraceptive intrauterine systems (LCS). The purpose of the study is to investigate which of the 2 administered doses is the lowest effective intrauterine dose of Levonorgestrel (LNG) administered via the LCS for contraception during 3 years. The study was amended: the LCS16 arm will be extended up to 5 years","primaryOutcome":{"measure":"Pearl Index up to 3 Years","timeFrame":"Up to 3 years","effectByArm":[{"arm":"LCS12","deltaMin":0.33,"sd":null},{"arm":"LCS16","deltaMin":0.31,"sd":null}],"pValues":[{"comp":"OG000","p":null},{"comp":"OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":136,"countries":["United States","Argentina","Canada","Chile","Finland","France","Hungary","Mexico","Netherlands","Norway","Sweden"]},"refs":{"pmids":["25661510","24726226","24240244","26378938"],"seeAlso":["http://www.clinicaltrialsregister.eu/"]},"adverseEventsSummary":{"seriousAny":{"events":66,"n":1432},"commonTop":["Ovarian cyst","Acne","Urinary tract infection","Headache","Vaginitis bacterial"]}}